Humalog Tempo Pen is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.
| Product ID | 0002-8213_13204abd-313e-4901-9cd8-62634c0f5966 | 
| NDC | 0002-8213 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Humalog Tempo Pen | 
| Generic Name | Insulin Lispro | 
| Dosage Form | Injection, Solution | 
| Route of Administration | SUBCUTANEOUS | 
| Marketing Start Date | 2017-06-06 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020563 | 
| Labeler Name | Eli Lilly and Company | 
| Substance Name | INSULIN LISPRO | 
| Active Ingredient Strength | 100 [iU]/mL | 
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2019-11-15 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA020563 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-11-15 | 
| Marketing Category | BLA | 
| Application Number | BLA020563 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-06-06 | 
| Ingredient | Strength | 
|---|---|
| INSULIN LISPRO | 100 [iU]/mL | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0002-7510 | Humalog | Insulin lispro | 
| 0002-7511 | Humalog | Insulin lispro | 
| 0002-7512 | Humalog | Insulin lispro | 
| 0002-7516 | Humalog | Insulin lispro | 
| 0002-7712 | Humalog | Insulin lispro | 
| 0002-7714 | Humalog | Insulin lispro | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() HUMALOG  74314093  1963572 Live/Registered  | 
        Eli Lilly and Company  1992-09-15  |